IP Library Granted Patent US 8,263,104
Granted Patent B2
US 8,263,104 · App. 12/135,640 · Granted Sep 11, 2012

Polymer nanofilm coatings

Assignees: Northwestern University; The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,104
App. No.
12/135,640
Granted
Sep 11, 2012
Kind
B2
Abstract

Disclosed herein are nanofilm coatings for implantable medical devices comprising a diblock or triblock copolymer (PEO-PMMA or PMOXA-PDMS-PMOXA, respectively). Such nanofilms, may be used, for example, as amphiphilic supports for therapeutic agents. These materials are conducive towards the formation of active substrates for a suite of biological and medical applications.

Claims (10)

1. An implantable medical device having one or more of its surfaces coated with a nanofilm composition comprising:

(a) a first layer comprising parylene;

(b) a second layer comprising a copolymer; and

(c) a third layer comprising nanoporous parylene,

wherein the copolymer is a triblock copolymer comprising polymethyloxazoline-polydimethylsiloxane-polymethyloxazoline, and wherein the nanofilm has a thickness between 0.1 nm and 20 nm.

2. The device of claim 1 , wherein said composition further comprises at least one therapeutic agent.

3. The device of claim 2 , wherein the at least one therapeutic agent is not a protein.

4. The device of claim 2 , wherein the at least one therapeutic agent is selected from the group consisting of: thrombin inhibitors, antithrombogenic agents, thrombolytic agents, fibrinolytic agents, vasospasm inhibitors, calcium channel blockers, vasodilators, antihypertensive agents, antimicrobial agents, antibiotics, inhibitors of surface glycoprotein receptors, antiplatelet agents, antimitotics, microtubule inhibitors, anti secretory agents, actin inhibitors, remodeling inhibitors, antisense nucleotides, anti metabolites, antiproliferatives, anticancer chemotherapeutic agents, anti-inflammatory steroid or non-steroidal anti-inflammatory agents, immunosuppressive agents, growth hormone antagonists, growth factors, dopamine agonists, radiotherapeutic agents, extracellular matrix components, inhibitors, free radical scavengers, chelators, antioxidants, anti polymerases, antiviral agents, photodynamic therapy agents, and gene therapy agents.

5. The device of claim 1 , wherein the copolymer comprises a single layer having a thickness from about 1 nm to about 10 nm.

6. The device of claim 1 , wherein the device comprises an electrode.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 9, 2011
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027358/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2008
From: CHENG, GENHONG; CHOW, EDWARD K.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 021528/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2008
From: HO, DEAN; CHEN, MARK; PIERSTORFF, ERIK; HUANG, HOUJIN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 021528/0516 →
Continuity (3)
Provisional Application 60942885 · Jun 8, 2007
Provisional Application 60981688 · Oct 22, 2007
Related Publication 20090004241A1 · Jan 1, 2009